DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

DOJ clears Cigna, Express Scripts deal The $52 billion mega-deal will move forward

Trimedx to acquire Aramark's health tech business for $300 million Expands reach to more than 500 healthcare providers

UPDATE: Agfa responds to acquisition interest from Kanteron Systems X-ray leader 'has decided not to engage in discussions' at this time

Dr. Charles Stacey Accreditation Council for Medical Affairs appoints Accera CEO to board of governors

Johnson & Johnson acquires Emerging Implant Technologies GmbH Company aims to improve spinal fusion technology and outcomes

Will Agfa-Gevaert be acquired by Kanteron Systems? Software company pitches buy, points to stagnant Agfa Healthcare revenue and synergies

Stryker to acquire Invuity for $7.40 per share in cash Develops tools to boost visualization during surgery

ScImage, Cardiac Imaging forge partnership Bringing 'anywhere, real-time' access to cardiology images

Philips acquires Air Force technology for mobile patient monitoring Real-time monitoring through nonexclusive patent license deal

From technology newcomers to data-driven wearable devices: The US healthcare market is quickly evolving Factors for success when prevention is better than a cure

Alliance completes deal for Piramal Imaging

by Thomas Dworetzky , Contributing Reporter
Alliance Medical Group (AMG), a division of Life Healthcare Group, has acquired Piramal Imaging.

The deal includes subsidiaries Piramal Imaging Ltd. and Piramal Imaging GmbH, and the firm's U.S. business.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



"The acquisition of Piramal Imaging further extends our molecular imaging capabilities, supplementing both our PET/CT scanning and radiopharmacy facilities services across Europe, and giving us access to new markets,” said Howard Marsh, managing director of molecular imaging at AMG, noting that the deal will permit the offering of a wider range of services, as well as development, production and imaging services “for new radiopharmaceuticals under the Life Healthcare brand."

AMG, which provides diagnostic imaging services and produces and distributes radiopharmaceutical products, has more than 60 PET/CT service locations and 10 radiopharmacies that make radiopharmaceuticals used throughout Europe.

Piramal Imaging is known for developing and commercializing molecular imaging agents used to address neurological, oncological, and cardiovascular diseases. The company was formed in 2012 as part of a deal to buy the molecular imaging research and development portfolio of Bayer Pharma AG. Its Neuraceq – florbetaben F18 – is approved for use in the diagnosis of Alzheimer's disease.

“Being part of the Life Healthcare Group,” said Ludger Dinkelborg, director of the Piramal Imaging board, “ensures seamless continuity in our current business. The combination provides us more opportunities to move forward with important products, such as Neuraceq for beta-amyloid imaging and our investigational tracer PI-2620 for tau imaging in patients with neurocognitive decline, and to develop our research pipeline."

Piramal Imaging will be combined with Life Radiopharma under the Life brand.

This move, stated the companies, will boost the availability of new imaging agents in clinics, while supporting the research community and pharma industry “by providing integrated biomarkers and imaging facilities in their clinical trials.”

In 2016, Life Healthcare acquired 95 percent of U.K.-based Alliance Medical Group, with senior management at Alliance taking the other five percent.

Life Healthcare CEO André Meyer said at that time that over the past few years, Life Healthcare had expanded into mental health, acute physical rehabilitation, renal dialysis and oncology, and that the deal represented “the entry into diagnostics as a natural evolution” of this strategy.

“In addition to investing in a growing developed market, the acquisition provides Life Healthcare with an opportunity to diversify into attractive new geographies with a strong basket of currencies. The transaction will also facilitate the transfer skill and expertise between our operations in India and Poland,” he noted at the time.

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED